News | July 03, 2025
Asahi Kasei Pharma starts Phase III study of promising CIPN prevention therapy
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
A triple-action Formula for comprehensive respiratory relief
Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
mRNA-1010 demonstrated superior relative vaccine efficacy
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
Subscribe To Our Newsletter & Stay Updated
